Search results
Find information on medicines authorised for human or veterinary use in the EU, including herbal products. Learn about EMA's role, services, databases, and latest news on medicines.
- National Registers
The national medicine registers in the different Member...
- Download
EMA, in cooperation with the World Health Organization...
- Background and Context
The European Medicines Agency (EMA) publishes detailed...
- What We Publish and When
Guide to information published on human medicines. EMA's...
- EMA
The European Medicines Agency (EMA) protects and promotes...
- Medicines Under Evaluation
Each month, the European Medicines Agency's (EMA) publishes...
- COVID-19 medicines
COVID-19 vaccines: strains, use and age ranges. The overview...
- Homepage
Featured news and updated for pharmaceutical industry...
- National Registers
Featured news and updated for pharmaceutical industry stakeholders active in the human and veterinary medicines fields.
La Agencia Europea de Medicamentos (EMA) protege y promueve la salud humana y animal mediante la evaluación y el seguimiento de los medicamentos en la Unión Europea (UE) y el Espacio Económico Europeo (EEE).
EMA is the EU agency that evaluates and monitors human and veterinary medicines in the EU and the EEA. It issues marketing authorisations, provides information to healthcare professionals and patients, and facilitates research into new medicines.
Each month, the European Medicines Agency's (EMA) publishes an updated list of medicines for human use currently under evaluation by EMA’s Committee for Medicinal Products for Human Use (CHMP) to obtain a marketing authorisation in the European Union (EU).
The national medicine registers in the different Member States of the European Union (EU) and European Economic Area (EEA) contain information on medicines authorised in those countries, including links for the summary of product characteristics (SmPC) and the package leaflet.
COVID-19 vaccines: strains, use and age ranges. The overview below summarises the characteristics of the COVID-19 vaccines authorised in the EU: This overview also details the composition of COVID-19 vaccines and the milestones for authorisation of adapted vaccines.
